Frontlight ResearchEarly access
CompletedNo phase
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
Key facts
- Who runs it
- AbbVie
- Where
- Baltimore, Columbus, Gainesville, Houston, New York, and Stanford, United StatesSee the 6 sites
- Trial code
- Status
- Completed
- People taking part
- 63 people enrolled
- Started
- 16 Sept 2021
- Ended
- 29 Feb 2024
- Type of study
- Observational
- Treatments tested
- CREON
- Record updated
- 28 March 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Medical history of chronic pancreatitis (CP)
- Diagnosis of Exocrine Pancreatic Insufficiency (EPI)
Who cannot take part
- --History of cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric bypass surgery, extensive bowel surgery, inflammatory bowel disease, celiac disease, irritable bowel syndrome
Where in United States
- John Hopkins UniversityBaltimore, United States
- The Ohio State University Wexner Medical CenterColumbus, United States
- University of Florida - ArcherGainesville, United States
- Baylor College of Medicine - Baylor Medical CenterHouston, United States
- NYU Langone HealthNew York, United States
- Stanford University School of MedStanford, United States
About the trial
What the trial wants to find out
Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.
The group in the trial
- Participants on CREON
Treatment: CREON
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
- Record updated
- 28 March 2024